96998 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Gastrins; Cholecystokinins [CCK]
Sub-classes:Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment
#2PROGASTRIN AS A BIOMARKER FOR IMMUNOTHERAPY
#3RADIOLABELED PROGASTRIN IN CANCER DIAGNOSIS
#4Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment
#5Coiled-coil connector
#6Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
#7Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment
#8Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
#9Immunogenic compositions comprising progastrin and uses thereof
#10Immunogenic compositions against human progastrin peptides
#11Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
#12Immunogenic compositions against human progastrin peptides
#13Long-acting gastrin derivatives
#14Diagnosis and treatment of epithelial cancers using labeled/conjugated progastrin peptides
#15Combined use of DPP-IV Inhibitors and Gastrin Compounds
#16Modified CCK peptides
#17Methods and compositions using CD3 agonists
#18Combined use of DPP-IV inhibitors and gastrin compounds
#19Treatment for Diabetes
#20TREATMENT OF DIABETES
#21Immunogenic compositions comprising progastrin and uses thereof
#22Peptide Stabilization
#23N and/or N derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH)(CO)] by coordination
#24Modified minigastrin analogs for oncology applications
#25Method of treatment
#26Treatment of diabetes
#27Methods of altering absorption of hydrophobic compounds
#28Methods for increasing the production of a recombinant polypeptide from a host cell
#29Hybrid polypeptides with selectable properties
#30Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
#31Prevention and treatment of hypergastrinemia
#32Conjugates of ligand linker and cytotoxic agent and related composition and methods of use
#33Immunological methods for the treatment of gastrointestinal cancer
#34Polymorphic DNAs and their use for diagnosis of susceptibility to panic disorder
#35Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)